Connection

David Amrol to Treatment Outcome

This is a "connection" page, showing publications David Amrol has written about Treatment Outcome.
Connection Strength

0.162
  1. Comparative Efficacy of Anti IL-4, IL-5 and IL-13 Drugs for Treatment of Eosinophilic Asthma: A Network Meta-analysis. Lung. 2018 10; 196(5):517-530.
    View in: PubMed
    Score: 0.069
  2. Cardiovascular safety of long acting beta agonist-inhaled corticosteroid combination products in adult patients with asthma: a systematic review. Lung. 2014 Feb; 192(1):47-54.
    View in: PubMed
    Score: 0.049
  3. Topical pimecrolimus in the treatment of human allergic contact dermatitis. Ann Allergy Asthma Immunol. 2003 Dec; 91(6):563-6.
    View in: PubMed
    Score: 0.025
  4. Rhinitis 2020: A?practice parameter update. J Allergy Clin Immunol. 2020 10; 146(4):721-767.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.